News

Artificial Intelligence Conferences | Oncodesign
A.I
28/04/2022

Places to meet and engage conversation with our experts in AI and Drug Discovery

Come back regularly to check if there is a meeting nearby your place to meet one of our experts in both AI & Drug Discovery.

Meet Oncodesign in person this spring
Corporate
Service
27/04/2022

[Congress] Meet Oncodesign in person this spring

Check out where to meet Oncodesign this spring... surely we can arrange a meeting somewhere.

Parkinson's disease | Oncodesign
Biotech
11/04/2022

Parkinson’s Disease: Growing Prevalence And Continued Significant Medical Need

Explore the disease & find out about our strategic R&D collaboration with Servier: info, press releases & video!

investors-oncodesign
Corporate
Financial
07/04/2022

Oncodesign confirms its very good results in 2021 and an attractive outlook for 2022

Read the full press release about our very good results in 2021 & an attractive outlook for 2022 for the group & our BUs Service, Biotech & AI.

Scientific Resources | Oncodesign
Service
28/03/2022

Scientific Posters | AACR 2022

Find all 4 posters that are presented during AACR 2022. They unveil our expertise in oncology using our scientific know-how (medicinal chemistry, radio-imaging, in vivo model and microbiome)

[CONGRESS] Microbiome & Probiotics
Service
18/03/2022

[Congress] AACR Annual Meeting | 8-13 April 2022

Meet us in person at the Annual Meeting of the AACR in New Orleans!

Oncology Webinar
Service
16/03/2022

[Webinar] How to better optimize an oncology drug discovery program

Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.

[CONGRESS] Microbiome & Probiotics
Service
14/03/2022

[CONGRESS] Microbiome & Probiotics, 29-30 March 2022

Meet us at the Microbiome & Probiotics congress in San Diego | March 2022. Explore our expertise in assessing the role of microbiome in drug discovery

Drive-Biologics - Discovery & Developement | Oncodesign
Service
24/02/2022

Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services

Abzena x Alira Health x Oncodesign: unveil unique integrated solution with specialist services, from biologics discovery to clinical & commercial manufacturing

Nanocyclix portfolio - R&D pipeline
Biotech
Financial
08/02/2022

SEngine Precision Medicine & Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment

Read all the details of the collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.

Financial Result oncodesign
Corporate
Financial
27/01/2022

Oncodesign announces a 2021 turnover of €31.3M, up by 22%, and expects to break even

Find all the 2021 financial information: 2021 turnover of €31.3M, up by 22%, and expects to break even and dive into the BU financial results

Service
14/01/2022

[Congress] Microbiome Movement Drug Development

Oncodesign will be at the digital event Microbiome Movement Drug Development. Take the opportunity to learn more about SOLO Microbiome.